What does Breast Imaging Reporting and Data System (BIRADS) category 4a indicate?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: April 3, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

BI-RADS Category 4a Definition

BI-RADS category 4a indicates a suspicious breast imaging finding with a low probability of malignancy, specifically greater than 2% but less than or equal to 10% likelihood of cancer, warranting tissue biopsy for definitive diagnosis.

Clinical Significance and Malignancy Risk

Category 4a represents the lowest suspicion level within the broader category 4 classification (suspicious abnormality). The finding is not sufficiently benign to allow imaging follow-up alone, but the probability of malignancy remains relatively low 1. This subcategory was created to stratify the wide range of malignancy risk (3-94%) that exists within the general category 4 designation 1.

Evidence-Based Malignancy Rates

Research validates the clinical utility of the 4a subcategory:

  • Mammography and ultrasound studies demonstrate positive predictive values (PPV) of 2.5-6% for category 4a lesions, falling within the BI-RADS-specified range 2, 3
  • A large retrospective study of 102 category 4a lesions found only 6% were malignant 3
  • MRI studies show similar PPV of 1.8-2.5% for category 4a assessments 2, 4

Management Recommendation

Core needle biopsy is the recommended next step for all category 4a lesions 5. While the malignancy probability is low, it exceeds the 2% threshold that separates probably benign (category 3) from suspicious findings requiring tissue diagnosis 1.

Important Clinical Caveats

  • Observation alone is not appropriate for category 4a lesions, despite the low malignancy rate
  • The subcategory assignment helps inform patient counseling about expected biopsy outcomes
  • Concordance between imaging findings and pathology results must be verified after biopsy 5
  • If pathology shows benign results that are image-concordant, follow-up imaging at 6-12 month intervals for 1-2 years is recommended before returning to routine screening 5

Common Pitfall

Some studies report higher PPVs for category 4a (34% in one series) 6, suggesting subjectivity in subcategory assignment remains a challenge. Radiologists should apply strict criteria to avoid overcalling lesions as 4a when they may warrant 4b or 4c designation, as this affects patient counseling and clinical decision-making 7.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.